DSpace
 

Researchspace >

Browsing by Author Kalombo, L

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 17 of 17
Issue DateTitleAuthor(s)
Oct-2012Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parametersTshweu, L; Katata, L; Naidoo, S; Kalombo, L; Swai, H
Oct-2012Design and formulation of nano-sized spray dried efavirenz. Part I: Influence of formulation parametersKatata, L; Tshweu, L; Naidoo, S; Kalombo, L; Swai, H
Mar-2012Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administrationSemete, B; Booysen, L; Kalombo, L; Ramalapa, B; Hayeshi, R; Swai, HS
Feb-2006Evaluation of nano encapsulation techniques in different polymeric system for the delivery of anti-tuberculosis drugs (ATD)Swai, H; Hillie, KT; Cingo, N; Kalombo, L; Legodi, M; Semete, B
1-Sep-2010In vitro characterisation of PLGA nanoparticles encapsulating rifampicin and isoniazid - Towards IVIVCBooysen, L; Semete-Makokotlela, B; Kalombo, L; Swai, H; Kotzé, AF
Oct-2010In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systemsSemete, B; Booysen, L; Lemmer, Y; Kalombo, L; Katata, L; Verschoor, J; Swai, HS
Feb-2013In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazidBooysen, LLIJ; Kalombo, L; Brooks, E; Hansen, R; Gilliland, J; Gruppo, V; Lungenhofer, P; Semete-Makokotlela, B; Swai, HS; Kotze, AF; Lenaerts, A; du Plessis, LH
1-Sep-2010Lipid containing nanodrug delivery system for the treatment of TuberculosisLemmer, Y; Semete, B; Kalombo, L; Ramalapa, B; Jones, AT; Swai, HS; Verschoor, JA
Jun-2008Nanoencapsulation of Mycolic acids as a deliverable to macrophagesBenadie, Y; Semete, B; Venter, L; Kalombo, L; Driver, C; Jones, AT; Swai, H; Verschoor, JA
Nov-2008Nanoencapsulation of mycolic acids as a deliverable to macrophages - 2nd CSIR Biennial ConferenceBenadie, Y; Semete, B; Venter, L; Kalombo, L; Driver, C; Jones, AT; Swai, H; Verschoor, JA
Oct-2013Nanoencapsulation of water-soluble drug, lamivudine, using a double emulsion spray-drying technique for improving HIV treatmentTshweu, L; Katata, L; Kalombo, L; Swai, H
2012Nanomedicine in the development of drugs for poverty-related diseasesHayeshi, R; Semete, B; Kalombo, L; Katata, L; Lemmer, Y; Melariri, P; Nyamboli, B; Swai, H
Nov-2008Novel nanoparticles for Tuberculosis chemotherapySemete, B; Kalombo, L; Chelule, P; Benadie, Y; Booysen, L; Katata, L; Naidoo, S; Swai, H
Jul-2012Permeation of PLGA nanoparticles across different in vitro modelsNkabinde, LA; Shoba-Zikhali, LN; Semete-Makokotlela, B; Kalombo, L; Swai, HS; Hayeshi, R; Naicker, B; Hillie, TK; Hamman, JH
Mar-2012Potential of improving the treatment of tuberculosis through nanomedicineSemete, B; Kalombo, L; Katata, L; Chelule, P; Booysen, L; Lemmer, Y; Naidoo, S; Ramalapa, B; Hayeshi, R; Swai, HS
Nov-2013Progress and potential of nanomedicine to address infectious diseases of povertyHayeshi, R; Semete, B; Kalombo, L; Lemmer, Y; Katata, L; Swai, H
Jun-2010Targeted nanodrug delivery systems for the treatment of TuberculosisLemmer, Y; Semete, B; Booysen, L; Kalombo, L; Katata, L; Jones, AT; Alexander, C; Khati, M; Swai, HS; Verschoor, JA
Showing results 1 to 17 of 17

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback